Takepron and disseminated intravascular coagulation Patient Reports February 13, 2012
Takepron Side Effects Report #5603402-0
Takepron side effect was reported by a Consumer or non-health professional from JAPAN on Jan 16, 2008. Female patient, 76 years of age, was diagnosed with gastric ulcer, osteoporosis
and was treated with Takepron. After drug was administered, patient experienced the following side effects: agranulocytosis, altered state of consciousness, blood culture positive, disseminated intravascular coagulation, faecal incontinence, neutrophil count decreased, septic shock, staphylococcal infection
, urinary incontinence
. Takepron dosage: 30 MG (30 MG, 1 - 2) 35 MG (35 MG, 1 - 30 MG (30 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with FOSAMAC, PREDNISOLONE, MAGNESIUM OXIDE. Patient died.Takepron Side Effects Report #5676750-6
Takepron side effect was reported by a Health Professional from JAPAN on Mar 12, 2008. Female patient, 76 years of age, was diagnosed with gastric ulcer, osteoporosis
and was treated with Takepron. After drug was administered, patient experienced the following side effects: agranulocytosis, altered state of consciousness, antinuclear antibody positive, blood pressure decreased, disseminated intravascular coagulation, faecal incontinence, hepatic necrosis, hepatitis acute, malaise. Takepron dosage: 30 MG (30 MG,1 IN 1 D). During the same period patient was treated with FOSAMAX, PREDNISOLONE, MAGNESIUM OXIDE. Patient died.Takepron Side Effects Report #5728425-2
Takepron side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2008. Female patient, 76 years of age, was diagnosed with gastric ulcer, osteoporosis
and was treated with Takepron. After drug was administered, patient experienced the following side effects: agranulocytosis, disseminated intravascular coagulation, hepatic necrosis, hepatitis acute, malaise, neutrophil count decreased, septic shock, staphylococcal infection
, white blood cell count decreased. Takepron dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with FOSAMAC, PREDNISOLONE, MAGNESIUM OXIDE. Patient died.
Takepron and disseminated intravascular coagulation 